ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
0,00%
Bitcoin
66.963,14
-0,16%
Brent Oil
83,76
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Neuronetics Inc (STIM)

  7. Neuronetics Inc (STIM) Notícias

STIM

Neuronetics (STIM)

Neuronetics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:STIM
DataHoraFonteTítuloCódigoCompanhia
15/05/202408:32GlobeNewswire Inc.Humana Is First Commercial Payer to Address TMS Therapy Coverage for AdolescentsNASDAQ:STIMNeuronetics Inc
07/05/202417:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STIMNeuronetics Inc
07/05/202408:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STIMNeuronetics Inc
07/05/202408:30GlobeNewswire Inc.Neuronetics Reports Record First Quarter 2024 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
03/05/202417:30GlobeNewswire Inc.Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:STIMNeuronetics Inc
01/05/202409:31GlobeNewswire Inc.NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness MonthNASDAQ:STIMNeuronetics Inc
23/04/202417:30GlobeNewswire Inc.Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference CallNASDAQ:STIMNeuronetics Inc
10/04/202409:31GlobeNewswire Inc.New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is VitalNASDAQ:STIMNeuronetics Inc
25/03/202409:30GlobeNewswire Inc.NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with DepressionNASDAQ:STIMNeuronetics Inc
07/03/202410:22GlobeNewswire Inc.Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care NetworkNASDAQ:STIMNeuronetics Inc
05/03/202409:30GlobeNewswire Inc.Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
01/03/202419:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STIMNeuronetics Inc
29/02/202418:10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STIMNeuronetics Inc
20/02/202410:30GlobeNewswire Inc.Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference CallNASDAQ:STIMNeuronetics Inc
14/02/202413:46Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:STIMNeuronetics Inc
12/02/202410:32GlobeNewswire Inc.Neuronetics Launches Latest Evolution in its TrakStar® Patient Data Management SystemNASDAQ:STIMNeuronetics Inc
06/02/202410:28GlobeNewswire Inc.NeuroStar TMS Patient Access Expands Through Lucet Health Policy UpdateNASDAQ:STIMNeuronetics Inc
10/01/202417:56Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:STIMNeuronetics Inc
08/01/202410:30GlobeNewswire Inc.Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:STIMNeuronetics Inc
18/12/202310:49GlobeNewswire Inc.Neuronetics Receives 510(k) Clearance for NeuroSite™ Coil Placement AccessoryNASDAQ:STIMNeuronetics Inc
04/12/202310:56GlobeNewswire Inc.NeuroStar TMS Receives Expanded Regulatory Approval in JapanNASDAQ:STIMNeuronetics Inc
15/11/202318:15GlobeNewswire Inc.Neuronetics to Present at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:STIMNeuronetics Inc
13/11/202310:57GlobeNewswire Inc.NeuroStar Elevates Depression Treatment with Cutting-Edge Technology AdvancementsNASDAQ:STIMNeuronetics Inc
09/11/202310:32GlobeNewswire Inc.Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy CoverageNASDAQ:STIMNeuronetics Inc
07/11/202309:30GlobeNewswire Inc.Neuronetics Reports Third Quarter 2023 Financial and Operating ResultsNASDAQ:STIMNeuronetics Inc
24/10/202309:30GlobeNewswire Inc.Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference CallNASDAQ:STIMNeuronetics Inc
16/10/202309:56GlobeNewswire Inc.Brain Stimulation Highlights Best Practices for Optimal TMS Treatment OutcomesNASDAQ:STIMNeuronetics Inc
03/10/202310:21GlobeNewswire Inc.Neuronetics Draws Down Remaining $22.5 Million Available Under Credit FacilityNASDAQ:STIMNeuronetics Inc
22/09/202317:14Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:STIMNeuronetics Inc
12/09/202309:56GlobeNewswire Inc.In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating DepressionNASDAQ:STIMNeuronetics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:STIM

Seu Histórico Recente

BIT
F18727
Vontobel Financial Produ...
LSE
TIGT
Troy Income & Growth
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados